Enrolling by Invitation
Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer
NCT07112209
- Conditions
- Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer
- Locations
-
- Southern Medical University Guangzhou, Guangdong, China